Aprepitant injectable emulsion

aprepitant · Heron Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aprepitant injectable emulsion, covering 2022-08-30 to 2022-08-30. Get the full timeline:

Most recent: Clinical Trial Update: Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1) [Phase 2]